quinolones, as well as vancomycin which often is the last drug that successfully treats 41 MRSA infections (2). Antibiotic resistance has become an increasingly serious health 42 care problem in the world (3). This has been aggravated by a collapse in the number 43 of approvals of new antibacterials in the past three decades (4).
44
Macrophages are professional phagocytes of the innate immune system, 45 providing a first line of defense against infections. It has been reported that 46 macrophages played an important role in the clearance of S. aureus in the infected 47 mice (5). Mice that were depleted of macrophages are susceptible to MRSA infection 48 (6). Nevertheless, some investigators have pointed out several characteristics that 49 MRSA may thwart the macrophage-mediated host defense (7). Macrophages can kill 50 bacteria directly through phagocytosis and indirectly via releasing inflammatory 51 molecules, nitric oxide (NO), as well as by secreting pro-inflammatory factors, such 52 as interleukin-6 (IL-6), IL-1β, and tumor necrosis factor-α (TNF-α) (8, 9) . 53 Macrophages are the first immune cells that are recruited to the infection site, and are 54 the main source of pro-inflammatory cytokines after activation (10 method (54) . Primers for the selected genes are given in Table I . 
